TP53 and renal cell carcinoma: Comprehensive characterization of stage I-IV RCC by The Cancer Genome Atlas (TCGA) demonstrated that the 8 most frequent mutations in RCC are: VHL, PBRM1, SETD2, KDM5C, PTEN, BAP1, MTOR, and TP53 [8].